Welcome to Pangaea insights
Our collective intelligence provides an unrivalled breadth and depth of knowledge.
Pangaea’s ongoing relationships with key industry stakeholders facilitate continuous updates and dissemination of relevant market intelligence. Check back often for new posts!
Pangaea Express: Mandatory Reporting by Hospitals of Serious ADRs and MDIs
July 9, 2019
The Regulations regarding mandatory reporting of serious adverse drug reactions (ADRs) and medical device incidents (MDIs) by hospitals, proposed last summer, have now been adopted and will come into effect by December 16, 2019.
Pangaea Express: Advisory Council of National Pharmacare Final Recommendations
June 13, 2019
Universal, single-payer, public pharmacare in Canada.
Pangaea Express: BC Bold on Biosimilars
May 28, 2019
It has been some time coming but the speculation is over now. BC is the first province to switch patients from certain innovator biologics to their biosimilars.
Pangaea Express: No more CADTH for Biosimilars
May 24, 2019
Biosimilars no longer need to be reviewed by CADTH.
Biologics and Biosimilars: Prescription Pathway and Points of Influence
May 17, 2019
For industry, the path of the biologic prescription, once written, may see a number of influence points that affect market share, marketing plans, patient support programs (PSPs) and prescribers.
Pangaea Express: Ontario Pharmacy Reimbursement and Payment Policies
April 29, 2019
Ontario’s Ministry of Health and Long-Term Care (MOHLTC) has proposed legislation regarding pharmacy reimbursement and payment policies.
Cross Border Sales of Prescription Drugs
April 26, 2019
The sale of Canadian prescription drugs to US citizens continues to garner attention from the FDA, US Senators, the media and American patients.
Pangaea Express: Amending the Food and Drug Regulations - Improving Access to Generics
April 2, 2019
The Feds are amending the Food and Drug Regulations to improve access to generics.
Pangaea Express: OHIP+ FAQs
March 14, 2019
The Ministry of Health and Long-Term Care released a list of FAQs for Ontario patients to better understand the upcoming changes of OHIP+, that are to be implemented April 1, 2019.
Pangaea Express: Health Canada Releases Revised Fee Proposal For Drugs & Medical Devices
May 28, 2018
Following the review of more than 100 submissions and 700 comments, Health Canada has considered the divergent views of various sectors to the October 2017 fee proposal and released its revisions.